| 4GV1 | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | 0XZ, GOL, TPO | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Discovery of 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin -4-yl)piperidine-4-carboxamide (AZD5363), an orally bioavailable, potent inhibitor of Akt kinases., Addie M, Ballard P, Buttar D, Crafter C, Currie GS, Davies BR, Debreczeni J, Dry H, Dudley P, Greenwood R, Johnson PD, Kettle JG, Lane C, Lamont G, Leach AG, Luke R, Morris J, Ogilvie D, Page K, Pass M, Pearson S, Ruston L, J Med Chem. 2013 Feb 11. PMID:23394218 | ||||||||||||||
| Data retrieval |
![]() |
| View 4GV1 in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |